Quick answer

For a few conditions, yes. For most, the data is thin. Evidence is strongest for chronic pain, nausea from chemotherapy, and muscle spasticity from multiple sclerosis. State cards cover many other conditions, but a qualifying list is not proof of benefit.

more on this topic

Conditions with the strongest evidence

Two rare childhood epilepsy syndromes, Dravet syndrome and Lennox-Gastaut syndrome, respond to purified CBD. That product, Epidiolex, is the one cannabis-derived drug with FDA approval.

what are the benefits of medical cannabis

Conditions with weak or mixed evidence

Risk factors that change the answer

Age under 25. The brain matures into the mid-20s. THC use in the teen years tracks with memory and attention problems.

medical cannabis side effects and risks

Pregnancy and breastfeeding. No safe dose is set.

Is Medical Cannabis Right for You? A Cost Guide

Heart disease. THC raises heart rate and blood pressure for a few hours.

Substance use history. About 3 in 10 people who use marijuana develop marijuana use disorder.

Drug interactions. CBD blocks liver enzymes in the CYP450 family. That raises blood levels of some blood thinners, seizure drugs, and transplant drugs.

How a state program works

38 states and the District of Columbia run medical cannabis programs as of 2025. A clinician reviews your records and certifies a diagnosis that appears on the state list. You pay a fee, file an application, and get a card. The card covers possession at licensed dispensaries in that state. It does not work across state lines. Federal law lists cannabis as a Schedule I drug.

Questions to ask a clinician

  1. What is my diagnosis, and is it on the state list?
  2. Which trials cover that diagnosis, and how many patients did they include?
  3. What product, what THC-to-CBD ratio, and what dose?
  4. Which of my prescriptions interact with CBD or THC?
  5. What result counts as success, and when do we stop?

Track the response

Pick one symptom and one scale, such as pain from 0 to 10. Write a score before the first dose. Record a score at the same hour each day. Set a review at 4 to 8 weeks. If the score does not change, stop the product. Bring the log to the next visit.

Where facts come from

State health department pages list qualifying conditions, fees, and card rules. FDA labels and the National Academies review carry the clinical data. Dispensary staff are not clinicians and cannot give a diagnosis.